PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-03-28

Date Title Company
28-Mar-2024 Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences AccessWire
28-Mar-2024 LFTD Partners Inc. to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on April 1, 2024 AccessWire
28-Mar-2024 Unify Medical Announces Todd Rasmussen, MD, as Special Consultant for Its Military Initiatives AccessWire
28-Mar-2024 Aragen operationalizes first phase of its Biologics manufacturing facility in India Aragen
28-Mar-2024 Elekta partners with MSD to enhance kidney cancer care using digital solutions Elekta
28-Mar-2024 Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development Intravacc and Primrose Bio
28-Mar-2024 NOVEL PSYCHEDELIC COMPOUND TO BE TESTED FOR TREATMENT OF ALCOHOL USE DISORDER Clerkenwell Health
28-Mar-2024 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC HUTCHMED
28-Mar-2024 Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025 Transgene
28-Mar-2024 Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources Officer Transgene
28-Mar-2024 New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens MSF
28-Mar-2024 Coave Therapeutics to Present at Upcoming Conferences Coave
28-Mar-2024 Rett Syndrome Research Trust selects PMD Solutions' RespiraSense In Their Upcoming US-Based Biosensor Validation Study - VIBRANT AccessWire
28-Mar-2024 Health eCareers and AMSA Announce New Partnership AccessWire
28-Mar-2024 INIZIO ENGAGE TARGETS HEALTH AND SAFETY IMPROVEMENTS FOR LONE WORKERS WITH APPLIED DRIVING PARTNERSHIP Inizio Engage
28-Mar-2024 Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors Sensitive to Obesity/Metabolic Hormones Newswire
28-Mar-2024 Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors Sensitive to Obesity/Metabolic Hormones AccessWire
28-Mar-2024 PM Society Digital Awards 2024 – Open for Entries PM Society
28-Mar-2024 Mann Eye Institute Welcomes Retina Specialist Dr. Gonzalez to Houston Team AccessWire
28-Mar-2024 How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together AccessWire